Page last updated: 2024-08-26

bosentan anhydrous and Chronic Lung Injury

bosentan anhydrous has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bir, F; Enli, Y; Ergin, H; Özdemir, ÖM; Şahin, B; Taban, Ö1
Bargalló, R; Bulbena, O; Gelpí, E; Peralta, C; Prats, N; Roselló-Catafau, J1

Other Studies

2 other study(ies) available for bosentan anhydrous and Chronic Lung Injury

ArticleYear
The effects of bosentan on hyperoxia-induced lung injury in neonatal rats.
    Pediatrics international : official journal of the Japan Pediatric Society, 2019, Volume: 61, Issue:11

    Topics: Actins; Animals; Animals, Newborn; Biomarkers; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperoxia; Immunohistochemistry; Injections, Intraperitoneal; Lung; Lung Injury; Rats; Rats, Wistar; Treatment Outcome

2019
Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion.
    Transplantation, 2000, Dec-27, Volume: 70, Issue:12

    Topics: Animals; Bosentan; Endothelin-1; Liver; Liver Transplantation; Lung Injury; Male; Microscopy, Electron; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides; Transplantation Conditioning; Tumor Necrosis Factor-alpha

2000